QUVIVIQ (daridorexant) – Europe's first dual orexin :

QUVIVIQ™ is indicated for the treatment of adult patients with insomnia characterized by symptoms present for at least three months and considerable impact...

Related Keywords

Germany , Italy , Canada , United Kingdom , Allschwil , Switzerland General , Switzerland , Italian , Great Britain , German , Jean Paul Clozel , Simon Jose , Idorsia Ltd , European Commission Decision Reliance Procedure , European Union , European Commission , Drug Administration , Health Canada , Regulatory Agency , Paul Clozel , Chief Executive Officer , Chief Commercial Officer , Lancet Neurology , Product Characteristics , Full Prescribing Information , Medication Guide , European Commission Decision Reliance , Swiss Stock Exchange Idia , Idorsia Pharmaceuticals Ltd ,